The level of B2M is elevated in aging process (Yang et al., 2017), Alzheimer’s disease (AD) and HIV-associated dementia (Mcarthur et al., 1992; Brew et al., 1996; Carrette et al., 2003). The gene discussed is B2M; the disease is dementia.